Steroid 5α-Reductase 2 Deficiency

David W. Russell, Jean D. Wilson

Research output: Chapter in Book/Report/Conference proceedingChapter

4 Scopus citations

Abstract

Loss-of-function mutations in the steroid 5α-reductase 2 gene (SRD5A2) cause a disorder of male sexual differentiation in which the prostate does not form and external genitalia develop along female lines. Failure to synthesize dihydrotestosterone in fetal tissues that give rise to the male urogenital tract underlies the phenotype that characterizes this disorder. Studies of the SRD5A2 gene and its encoded enzyme at the molecular, biochemical, and endocrinological levels established the crucial role of dihydrotestosterone in formation of the male phenotype and in many other androgen actions and led to the development of drugs for the treatment of prostatic disease.

Original languageEnglish (US)
Title of host publicationGenetic Steroid Disorders
PublisherElsevier Inc.
Pages199-214
Number of pages16
ISBN (Print)9780124160064
DOIs
StatePublished - Sep 2013

    Fingerprint

Keywords

  • Ambiguous genitalia
  • Androgen action
  • Dihydrotestosterone
  • Disorders of sexual differentiation (DSD)
  • Gender identity/gender role behavior

ASJC Scopus subject areas

  • Dentistry(all)
  • Medicine(all)

Cite this

Russell, D. W., & Wilson, J. D. (2013). Steroid 5α-Reductase 2 Deficiency. In Genetic Steroid Disorders (pp. 199-214). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-416006-4.00014-4